Eli Lilly and Company (LLY)
NYSE: LLY · IEX Real-Time Price · USD
804.62
-16.57 (-2.02%)
At close: Jul 26, 2024, 4:00 PM
803.38
-1.24 (-0.15%)
After-hours: Jul 26, 2024, 7:48 PM EDT
Eli Lilly Market Cap
Eli Lilly has a market cap or net worth of $764.71 billion as of July 26, 2024. Its market cap has increased by 85.32% in one year.
Market Cap
764.71B
Enterprise Value
788.34B
1-Year Change
85.32%
Ranking
Category
Stock Price
$804.62
Market Cap Chart
Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $764.71B, an increase of 670.51%. That is a compound annual growth rate of 8.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 26, 2024 | 764.72B | 38.19% |
Dec 29, 2023 | 553.37B | 59.19% |
Dec 30, 2022 | 347.61B | 31.56% |
Dec 31, 2021 | 264.23B | 63.60% |
Dec 31, 2020 | 161.51B | 27.99% |
Dec 31, 2019 | 126.19B | 2.94% |
Dec 31, 2018 | 122.58B | 31.81% |
Dec 29, 2017 | 93.00B | 14.54% |
Dec 30, 2016 | 81.20B | -13.04% |
Dec 31, 2015 | 93.37B | 21.55% |
Dec 31, 2014 | 76.82B | 33.69% |
Dec 31, 2013 | 57.46B | 0.39% |
Dec 31, 2012 | 57.23B | 18.95% |
Dec 30, 2011 | 48.12B | 19.08% |
Dec 31, 2010 | 40.41B | -1.52% |
Dec 31, 2009 | 41.03B | -10.38% |
Dec 31, 2008 | 45.79B | -24.40% |
Dec 31, 2007 | 60.56B | 2.72% |
Dec 29, 2006 | 58.96B | -8.34% |
Dec 30, 2005 | 64.32B | 0.16% |
Dec 31, 2004 | 64.22B | -18.68% |
Dec 31, 2003 | 78.97B | 10.71% |
Dec 31, 2002 | 71.33B | -19.21% |
Dec 31, 2001 | 88.30B | -15.83% |
Dec 29, 2000 | 104.90B | 44.66% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Novo Nordisk | 581.89B |
UnitedHealth Group | 515.12B |
Johnson & Johnson | 384.20B |
AbbVie | 321.69B |
Merck & Co. | 318.75B |
AstraZeneca | 243.45B |
Thermo Fisher | 226.93B |
Novartis AG | 215.08B |